INDIE SEMICONDUCTOR INC-A (INDI)

US45569U1016 - Common Stock

4.1  -0.04 (-0.97%)

After market: 4.1017 +0 (+0.04%)

Fundamental Rating

3

INDI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of INDI have multiple concerns. INDI is valued quite expensive, but it does show an excellent growth.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

INDI had negative earnings in the past year.
INDI had a negative operating cash flow in the past year.
In the past 5 years INDI always reported negative net income.
In the past 5 years INDI always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of INDI (-14.38%) is worse than 75.93% of its industry peers.
INDI's Return On Equity of -25.01% is on the low side compared to the rest of the industry. INDI is outperformed by 76.85% of its industry peers.
Industry RankSector Rank
ROA -14.38%
ROE -25.01%
ROIC N/A
ROA(3y)-13.41%
ROA(5y)-82.76%
ROE(3y)-22.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

INDI has a Gross Margin of 40.87%. This is comparable to the rest of the industry: INDI outperforms 42.59% of its industry peers.
INDI's Gross Margin has declined in the last couple of years.
INDI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

INDI does not have a ROIC to compare to the WACC, probably because it is not profitable.
INDI has more shares outstanding than it did 1 year ago.
The debt/assets ratio for INDI has been reduced compared to a year ago.

2.2 Solvency

INDI has an Altman-Z score of 0.52. This is a bad value and indicates that INDI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.52, INDI is not doing good in the industry: 74.07% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.34 indicates that INDI is not too dependend on debt financing.
INDI has a Debt to Equity ratio of 0.34. This is in the lower half of the industry: INDI underperforms 64.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 0.52
ROIC/WACCN/A
WACC14.06%

2.3 Liquidity

INDI has a Current Ratio of 2.39. This indicates that INDI is financially healthy and has no problem in meeting its short term obligations.
INDI has a worse Current ratio (2.39) than 60.19% of its industry peers.
A Quick Ratio of 1.87 indicates that INDI should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.87, INDI perfoms like the industry average, outperforming 47.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.39
Quick Ratio 1.87

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.08% over the past year.
INDI shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.97%.
The Revenue has been growing by 114.54% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)23.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.5%
Revenue 1Y (TTM)22.97%
Revenue growth 3Y114.54%
Revenue growth 5YN/A
Sales Q2Q%-10.77%

3.2 Future

The Earnings Per Share is expected to grow by 45.75% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 26.03% on average over the next years. This is a very strong growth
EPS Next Y-22.65%
EPS Next 2Y33.66%
EPS Next 3Y45.75%
EPS Next 5YN/A
Revenue Next Year-3.94%
Revenue Next 2Y16.21%
Revenue Next 3Y26.03%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for INDI. In the last year negative earnings were reported.
Also next year INDI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as INDI's earnings are expected to grow with 45.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.66%
EPS Next 3Y45.75%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for INDI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INDIE SEMICONDUCTOR INC-A

NASDAQ:INDI (12/20/2024, 8:18:30 PM)

After market: 4.1017 +0 (+0.04%)

4.1

-0.04 (-0.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners84.84%
Inst Owner Change11.52%
Ins Owners1.28%
Ins Owner Change-5.77%
Market Cap827.87M
Analysts81.43
Price Target8.46 (106.34%)
Short Float %15.63%
Short Ratio5.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.06%
Min EPS beat(2)2.28%
Max EPS beat(2)5.84%
EPS beat(4)2
Avg EPS beat(4)-7.84%
Min EPS beat(4)-32.21%
Max EPS beat(4)5.84%
EPS beat(8)4
Avg EPS beat(8)-5.82%
EPS beat(12)8
Avg EPS beat(12)-1.1%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.88%
Min Revenue beat(2)-4.51%
Max Revenue beat(2)-1.26%
Revenue beat(4)0
Avg Revenue beat(4)-4.91%
Min Revenue beat(4)-8.62%
Max Revenue beat(4)-1.26%
Revenue beat(8)0
Avg Revenue beat(8)-3.14%
Revenue beat(12)1
Avg Revenue beat(12)-2.3%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.69%
PT rev (3m)-8.3%
EPS NQ rev (1m)1.98%
EPS NQ rev (3m)-5184.96%
EPS NY rev (1m)3.17%
EPS NY rev (3m)3.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-31.38%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.62
P/FCF N/A
P/OCF N/A
P/B 1.81
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.3
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS1.13
BVpS2.27
TBVpS-0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.38%
ROE -25.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.87%
FCFM N/A
ROA(3y)-13.41%
ROA(5y)-82.76%
ROE(3y)-22.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.88%
GM growth 5YN/A
F-Score3
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 48.84%
Cap/Sales 7.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.39
Quick Ratio 1.87
Altman-Z 0.52
F-Score3
WACC14.06%
ROIC/WACCN/A
Cap/Depr(3y)53.11%
Cap/Depr(5y)45.17%
Cap/Sales(3y)6.99%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.5%
EPS Next Y-22.65%
EPS Next 2Y33.66%
EPS Next 3Y45.75%
EPS Next 5YN/A
Revenue 1Y (TTM)22.97%
Revenue growth 3Y114.54%
Revenue growth 5YN/A
Sales Q2Q%-10.77%
Revenue Next Year-3.94%
Revenue Next 2Y16.21%
Revenue Next 3Y26.03%
Revenue Next 5YN/A
EBIT growth 1Y-9.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-29.16%
EBIT Next 3Y51.96%
EBIT Next 5YN/A
FCF growth 1Y-2.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.15%
OCF growth 3YN/A
OCF growth 5YN/A